Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oldaram 100mg modified-release tablets
040702040BQAAAC
|
Oldaram | Tramadol hydrochloride | Central Nervous System | 1 |
|
Onexila XL 10mg tablets
0407020ADBQAAAF
|
Onexila XL | Oxycodone hydrochloride | Central Nervous System | 1 |
|
Opiodur 25micrograms/hour transdermal patches (RX Farma)
0407020A0BRAGAE
|
Opiodur | Fentanyl | Central Nervous System | 1 |
|
Opiodur 75micrograms/hour transdermal patches (Pfizer)
0407020A0BRACAG
|
Opiodur | Fentanyl | Central Nervous System | 1 |
|
Orlept 500mg gastro-resistant tablets
0408010W0BEABAD
|
Orlept | Sodium valproate | Central Nervous System | 1 |
|
Orlept SF 200mg/5ml liquid
0408010W0BEACAA
|
Orlept | Sodium valproate | Central Nervous System | 1 |
|
Ospolot 50mg tablets
0408010Y0BBAAAA
|
Ospolot | Sultiame | Central Nervous System | 1 |
|
Oxitriptan 100mg tablets
0403040R0AAAJAJ
|
Oxitriptan | Oxitriptan | Central Nervous System | 1 |
|
Oxyargin 40mg/20mg modified-release tablets
0407020AFBDADAD
|
Oxyargin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1 |
|
Oxyargin 5mg/2.5mg modified-release tablets
0407020AFBDAAAC
|
Oxyargin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 1 |
|
Paldesic paracetamol 120mg/5ml oral suspension
0407010H0BCABAI
|
Paldesic | Paracetamol | Central Nervous System | 1 |
|
Paliperidone 1g/5ml prolonged-release inj pf syringes
0402020ABAAAJAJ
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 1 |
|
Paracetamol 650mg / Phenylephrine 10mg oral powder sachets
0407010ABAAAAAA
|
Paracetamol/phenylephrine hydrochloride | Paracetamol and phenylephrine hydrochloride | Central Nervous System | 1 |
|
Phenobarbital 150mg/5ml oral liquid
0408010N0AADADA
|
Phenobarbital | Phenobarbital | Central Nervous System | 1 |
|
Phenobarbital sodium 150mg/5ml oral liquid
0408010P0AABIBI
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | 1 |
|
Phenobarbital sodium 20mg/5ml oral liquid
0408010P0AABKBK
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | 1 |
|
Phenobarbital sodium 25mg/5ml oral liquid
0408010P0AAAWAW
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | 1 |
|
Pregabalin 165mg modified-release tablets
0408010AEAABBBB
|
Pregabalin | Pregabalin | Central Nervous System | 1 |
|
Pregabalin 330mg modified-release tablets
0408010AEAABCBC
|
Pregabalin | Pregabalin | Central Nervous System | 1 |
|
Pregabalin 82.5mg modified-release tablets
0408010AEAABDBD
|
Pregabalin | Pregabalin | Central Nervous System | 1 |
|
Prochlorperazine 25mg suppositories
0406000T0AAAFAF
|
Prochlpzine maleate | Prochlorperazine maleate | Central Nervous System | 1 |
|
Psytixol 200mg/1ml solution for injection ampoules
0402020G0BCAEAI
|
Psytixol | Flupentixol decanoate | Central Nervous System | 1 |
|
Ranfaxine XL 150mg capsules
0403040W0BQABAE
|
Ranfaxine | Venlafaxine | Central Nervous System | 1 |
|
Rewisca 150mg capsules
0408010AEBCAEAE
|
Rewisca | Pregabalin | Central Nervous System | 1 |
|
Risperidone 250micrograms/5ml oral suspension
040201030AAASAS
|
Risperidone (Systemic) | Risperidone | Central Nervous System | 1 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.